BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 8355890)

  • 21. Economic evaluation of immunoglobulin replacement in patients with primary antibody deficiencies.
    Beauté J; Levy P; Millet V; Debré M; Dudoit Y; Le Mignot L; Tajahmady A; Thomas C; Suarez F; Pellier I; Hermine O; Aladjidi N; Mahlaoui N; Fischer A;
    Clin Exp Immunol; 2010 May; 160(2):240-5. PubMed ID: 20041884
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Hospitals poised to offer in-home i.v. therapy.
    Robinson ML
    Hospitals; 1989 Jul; 63(14):16, 20. PubMed ID: 2666297
    [No Abstract]   [Full Text] [Related]  

  • 23. The home infusion industry: patients' angel or their ruthless plunderer?
    Margolis RE
    Healthspan; 1993 Jun; 10(6):18-20. PubMed ID: 10127303
    [No Abstract]   [Full Text] [Related]  

  • 24. Linezolid versus vancomycin for prosthetic joint infections: a cost analysis.
    You JH; Lee GC; So RK; Cheung KW; Hui M
    Infection; 2007 Jun; 35(4):265-70. PubMed ID: 17646907
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Medicare program; payment for home intravenous drug therapy services--HCFA. Proposed rule.
    Fed Regist; 1989 Nov; 54(215):46938-53. PubMed ID: 10303985
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Economics of home intravenous services.
    Thickson ND
    Pharmacoeconomics; 1993 Mar; 3(3):220-7. PubMed ID: 10146945
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A review of the Manitoba home i.v. antibiotic program.
    Cote D; Oruck J; Thickson N
    Can J Hosp Pharm; 1989 Aug; 42(4):137-41. PubMed ID: 10294299
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Safety, efficacy, and cost savings in an outpatient intravenous antibiotic program.
    Williams DN; Bosch D; Boots J; Schneider J
    Clin Ther; 1993; 15(1):169-79; discussion 168. PubMed ID: 8458046
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Home intravenous antibiotic therapy in Arkansas.
    Graves G; Jackson JP; Maxwell A; Woods T
    J Ark Med Soc; 1987 Jun; 84(1):55-7. PubMed ID: 2956246
    [No Abstract]   [Full Text] [Related]  

  • 30. Unissued rules worry home care providers.
    Lutz S
    Mod Healthc; 1989 Sep; 19(35):34, 36. PubMed ID: 10303811
    [No Abstract]   [Full Text] [Related]  

  • 31. I.v. therapy: the legislative and regulatory arena.
    Hughes C; Berke D
    Caring; 1990 May; 9(5):4-7. PubMed ID: 10106790
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Bears circle Medical Care America.
    Lutz S
    Mod Healthc; 1993 Mar; 23(10):17. PubMed ID: 10124321
    [No Abstract]   [Full Text] [Related]  

  • 33. Cost of home and hospital care for patients with cystic fibrosis followed up in two reference medical centers in France.
    Horvais V; Touzet S; François S; Bourdy S; Bellon G; Colin C; Durieu I
    Int J Technol Assess Health Care; 2006; 22(4):525-31. PubMed ID: 16984688
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Benefits to hospitals of sole home infusion therapy providers.
    Enriquez N; Conte R
    Am J Hosp Pharm; 1992 Nov; 49(11):2707-8. PubMed ID: 1471633
    [No Abstract]   [Full Text] [Related]  

  • 35. Home i.v. market is healthy hospital option.
    Souhrada L
    Hospitals; 1989 Feb; 63(3):54. PubMed ID: 2912857
    [No Abstract]   [Full Text] [Related]  

  • 36. Assessment of the need for a home intravenous antibiotic program.
    Lee K; Andrews JD
    Can J Hosp Pharm; 1988 Dec; 41(6):295-301, 307. PubMed ID: 10291354
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Comparative study of health care costs for patients using home oxygen therapy or those in waiting lists].
    Maquilón C; Chiong H; Bello S; Naranjo C; Lira P; Díaz M
    Rev Med Chil; 2001 Dec; 129(12):1395-403. PubMed ID: 12080877
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Home health PPS: new payment system, new hope.
    St Pierre M; Dombi WA
    Caring; 2000 Jan; 19(1):6-11. PubMed ID: 10787823
    [TBL] [Abstract][Full Text] [Related]  

  • 39. T2 agrees to 4-way merger that will create 2nd-largest home infusion company.
    Burns J
    Mod Healthc; 1994 Feb; 24(7):32. PubMed ID: 10131772
    [No Abstract]   [Full Text] [Related]  

  • 40. [Economic evaluation of at home subcutaneous and intravenous immunoglobulin substitution].
    Haddad L; Perrinet M; Parent D; Leroy-Cotteau A; Toguyeni E; Condette-Wojtasik G; Hachulla E
    Rev Med Interne; 2006 Dec; 27(12):924-6. PubMed ID: 17011081
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.